Indoxyl sulfate induces complex redox alterations in mesangial cells

American Journal of Physiology - Renal Physiology

Volumn 290, Issue 6, 2006, Pages

  Gelasco, Andrew K ^a   Raymond, John R ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

Electron paramagnetic spin resonance; Fluorescence; Microphysiometry; NADPH oxidase; Reactive oxygen species; Superoxide; Uremic toxins

Indexed keywords

FLUORESCENT DYE; INDICAN; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE SULFUR SPECIES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UREMIC TOXIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; FLUORESCENCE; HUMAN; KIDNEY CELL; KIDNEY FAILURE; MALE; MESANGIUM CELL; METHODOLOGY; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT;

EID: 33744809267     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00281.2004     Document Type: Article

References (42)

1. Aoyama I and Niwa T. An oral adsorbent ameliorates renal overload of indoxyl sulfate and progression of renal failure in diabetic rats. Am J Kidney Dis 37: S7-S12, 2001.
2. Aoyama I, Shimokata K, and Niwa T. An oral adsorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis in diabetic rats. Nephron 92: 635-651, 2002.
3. Bowmer CJ and Lindup WE. Decreased drug binding in uraemia: effect of indoxyl sulphate and other endogenous substances on the binding of drugs and dyes to human albumin. Biochem Pharmacol 31: 319-323, 1982.
4. Budisavljevic MN, Hodge L, Barber K, Fulmer JR, Durazo-Arvizu RA, Self SE, Kuhlmann M, Raymond JR, and Greene EL. Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis. Am J Physiol Renal Physiol 285: F1138-F1148, 2003.
5. Dasgupta A and Thompson WC. Carbamazepine-salicylate interaction in normal and uremic sera: reduced interaction in uremic sera. Ther Drug Monit 17: 199-202, 1995.
6. Deguchi T, Kusuhara H, Takadate A, Endou H, Otagiri M, and Sugiyama Y. Characterization of uremic toxin transport by organic anion transporters in the kidney. Kidney Int 65: 162-174, 2004.
7. Deguchi T, Ohtsuki S, Otagiri M, Takanaga H, Asaba H, Mori S, and Terasaki T. Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. Kidney Int 61: 1760-1768, 2002.
8. Dikalov S, Fink B, Skatchkov M, Sommer O, and Bassenge E. Formation of reactive oxygen species in various vascular cells during glyceryltrinitrate metabolism. J Cardiovasc Pharmacol Ther 3: 51-62, 1998.
9. Dikalov S, Grigor'ev IA, Voinov M, and Bassenge E. Detection of superoxide radicals and peroxynitrite by 1-hydroxy-4-phosphonooxy-2,2,6,6- tetramethylpiperidine: quantification of extracellular superoxide radicals formation. Biochem Biophys Res Commun 248: 211-215, 1998.
10. Dikalov S, Skatchkov M, and Bassenge E. Spin trapping of superoxide radicals and peroxynitrite by 1-hydroxy-3-carboxy-pyrrolidine and 1-hydroxy-2,2,6, 6-tetramethyl-4-oxo-piperidine and the stability of corresponding nitroxyl radicals towards biological reductants. Biochem Biophys Res Commun 231: 701-704, 1997.
11. Dikalov S, Skatchkov M, Fink B, and Bassenge E. Quantification of superoxide radicals and peroxynitrite in vascular cells using oxidation of sterically hindered hydroxylamines and electron spin resonance. Nitric Oxide 1: 423-431, 1997.
12. Duling DR. Simulation of multiple isotropic spin-trap EPR spectra. J Magn Reson B 104: 105-110, 1994.
13. Enomoto A, Takeda M, Taki K, Takayama F, Noshiro R, Niwa T, and Endou H. Interactions of human organic anion as well as cation transporters with indoxyl sulfate. Eur J Pharmacol 466: 13-20, 2003.
14. Enomoto A, Takeda M, Tojo A, Sekine T, Cha SH, Khamdang S, Takayama F, Aoyama I, Nakamura S, Endou H, and Niwa T. Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. J Am Soc Nephrol 13: 1711-1720, 2002.
15. Fagugli RM, De Smet R, Buoncristiani U, Lameire N, and Vanholder R. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. Am J Kidney Dis 40: 339-347, 2002.
16. Fenton HJH. The oxidation of tartaric acid in presence of iron. J Chem Soc Proc 10: 157-158, 1894.
17. Fink B, Dikalov S, and Bassenge E. A new approach for extracellular spin trapping of nitroglycerin-induced superoxide radicals both in vitro and in vivo. Free Radic Biol Med 28: 121-128, 2000.
18. Floege J, Eng E, Young BA, and Johnson RJ. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int Suppl 39: S47-S54, 1993.
19. Gaertner SA, Janssen U, Ostendorf T, Koch KM, Floege J, and Gwinner W. Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 13: 2930-2937, 2002.
20. Gorin Y, Kim NH, Feliers D, Bhandari B, Choudhury GG, and Abboud HE. Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase. FASEB J 15: 1909-1920, 2001.
21. Gorin Y, Ricono JM, Kim NH, Bhandari B, Choudhury GG, and Abboud HE. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol 285: F219-F229, 2003.
22. Gorin Y, Ricono JM, Wagner B, Kim NH, Bhandari B, Ghosh Choudhury G, and Abboud HE. Angiotensin II-induced ERK1/2 activation and protein synthesis are redox-dependent in glomerular mesangial cells. Biochem J 381: 231-239, 2004.
23. 2 generation in rat renal mesangial cells. Am J Physiol Renal Physiol 278: F650-F658, 2000.
24. 2A receptor induces TGF-β1 expression in mesangial cells via ERK: proliferative and fibrotic signals. Am J Physiol Renal Physiol 276: F922-F930, 1999.
25. Kamanna VS, Pai R, Roh DD, and Kirschenbaum MA. Oxidative modification of low-density lipoprotein enhances the murine mesangial cell cytokines associated with monocyte migration, differentiation, and proliferation. Lab Invest 74: 1067-1079, 1996.
26. Kato A, Odamaki M, and Hishida A. Association between blood indoxyl sulfate and carbonyl stress marker in hemodialysis patients. Clin Nephrol 60: 161-167, 2003.
27. Martinez-Salgado C, Eleno N, Tavares P, Rodriguez-Barbero A, Garcia-Criado J, Bolanos JP, and Lopez-Novoa JM. Involvement of reactive oxygen species on gentamicin-induced mesangial cell activation. Kidney Int 62: 1682-1692, 2002.
28. Mori S, Takanaga H, Ohtsuki S, Deguchi T, Kang YS, Hosoya K, and Terasaki T. Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J Cereb Blood Flow Metab 23: 432-440, 2003.
29. iβγ stimulates mitogen-activated protein kinase via NAD(P)H oxidase and reactive oxygen species upstream of src in Chinese hamster ovary fibroblasts. Biochem J 347: 61-67, 2000.
30. Niwa T, Aoyama I, Takayama F, Tsukushi S, Miyazaki T, Owada A, and Shiigai T. Urinary indoxyl sulfate is a clinical factor that affects the progression of renal failure. Miner Electrolyte Metab 25: 118-122, 1999.
31. Niwa T and Ise M. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 124: 96-104, 1994.
32. Niwa T, Tsukushi S, Ise M, Miyazaki T, Tsubakihara Y, Owada A, and Shiigai T. Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. Miner Electrolyte Metab 23: 179-184, 1997.
33. Niwa T, Yazawa T, Ise M, Sugano M, Kodama T, Uehara Y, and Maeda K. Inhibitory effect of oral sorbent on accumulation of albumin-bound indoxyl sulfate in serum of experimental uremic rats. Nephron 57: 84-88, 1991.
34. Ohtsuki S, Asaba H, Takanaga H, Deguchi T, Hosoya K, Otagiri M, and Terasaki T. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem 83: 57-66, 2002.
35. Olive G, Mercier A, Le Moigne F, Rockenbauer A, and Tordo P. 2-Ethoxycarbonyl-2-methyl-3,4-dihydro-2H-pyrrole-1-oxide: evaluation of the spin trapping properties. Free Radic Biol Med 28: 403-408, 2000.
36. Saito K, Takeshita K, Anzai K, and Ozawa T. Pharmacokinetic study of acyl-protected hydroxylamine probe, 1-acetoxy-3-carbamoyl-2,2,5,5- tetramethylpyrrolidine, for in vivo measurements of reactive oxygen species. Free Radic Biol Med 36: 517-525, 2004.
37. Sakai T, Maruyama T, Imamura H, Shimada H, and Otagiri M. Mechanism of stereoselective serum binding of ketoprofen after hemodialysis. J Pharmacol Exp Ther 278: 786-792, 1996.
38. Sakai T, Takadate A, and Otagiri M. Characterization of binding site of uremic toxins on human serum albumin. Biol Pharm Bull 18: 1755-1761, 1995.
39. Sakai T, Yamasaki K, Sako T, Kragh-Hansen U, Suenaga A, and Otagiri M. Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin. Pharm Res 18: 520-524, 2001.
40. Stolze K, Udilova N, and Nohl H. Spin adducts of superoxide, alkoxyl, and lipid-derived radicals with EMPO and its derivatives. Biol Chem 383: 813-820, 2002.
41. United States Renal Data System. U.S. Renal Data System 2003 Annual Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003.
42. Zhang H, Joseph J, Vasquez-Vivar J, Karoui H, Nsanzumuhire C, Martasek P, Tordo P, and Kalyanaraman B. Detection of superoxide anion using an isotopically labeled nitrone spin trap: potential biological applications. FEBS Lett 473: 58-62, 2000.